A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia.

Autor: Maroc, N.¹ maroc@ipsogen.com, Morel, A.¹, Beillard, E.², Chapelle, A.L. De La¹, Fund, X.³, Mozziconacci, M.-J.⁴, Dupont, M.⁵, Cayuela, J.-M.³, Gabert, J.², Koki, A.¹, Fert, V.¹, Hermitte, F.¹, De La Chapelle, A L (AUTHOR)

Publikováno v: Leukemia (08876924). Sep2004, Vol. 18 Issue 9, p1522-1530. 9p.

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

Autor: Jovanovic, J.V., Ivey, A., Vannucchi, A.M., Lippert, E., Leibundgut, E. Oppliger, Cassinat, B., Pallisgaard, N., Maroc, N., Hermouet, S., Nickless, G., Guglielmelli, P., Reijden, B.A. van der, Jansen, J.H., Alpermann, T., Schnittger, S., Bench, A., Tobal, K., Wilkins, B., Cuthill, K., McLornan, D., Yeoman, K., Akiki, S., Bryon, J., Jeffries, S., Jones, A., Percy, M.J., Schwemmers, S., Gruender, A., Kelley, T.W., Reading, S., Pancrazzi, A., McMullin, M.F., Pahl, H.L., Cross, N.C., Harrison, C.N., Prchal, J.T., Chomienne, C., Kiladjian, J.J., Barbui, T., Grimwade, D.

Publikováno v: Jovanovic, J V; Ivey, A; Vannucchi, A M; Lippert, E; Oppliger Leibundgut, Elisabeth; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, P; van der Reijden, B A; Jansen, J H; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; McLornan, D; ... (2013). Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia, 27(10), pp. 2032-2039. Nature Publishing Group 10.1038/leu.2013.219
Leukemia
Leukemia, 27, 2032-9
Leukemia, 27, 10, pp. 2032-9

Item does not contain fulltext Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8db0b9a0e0a05667e1f59be8f8b90e3d
https://doi.org/10.1038/leu.2013.219

Systematic Evaluation of DNA-Based Quantitative-Polymerase Chain Reaction (Q-PCR) Assays to Track Treatment Response in Patients with JAK2-V617F Associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/ MPN&MPNr-EuroNet Study

Autor: Jovanovic, J V ^*, Vannucchi, A M, Lippert, E ^*, Leibundgut, E Oppliger ^*, Maroc, N ^*, Hermouet, S, Nickless, G ^*, Cassinat, B ^*, Guglielmelli, P ^*, van der Reijden, B, Bench, A ^*, Tobal, K ^*, Wilkins, B ^*, Cuthill, K ^*, Ivey, A ^*, Yeoman, K ^*, Percy, M J, Schwemmers, S ^*, Gruender, A ^*, Kelley, T W, Reading, S ^*, Pancrazzi, A ^*, McMullin, MF, Pahl, H L, Harrison, C N, Prchal, J T, Chomienne, C ^*, Kiladjian, JJ, Barbui, T ^*, Grimwade, D

Publikováno v: In Blood 18 November 2011 118(21):2812-2812

Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase

Autor: Maroc, N., Robert Rottapel, Rosnet, O., Marchetto, S., Lavezzi, C., Mannoni, P., Birnbaum, D., Dubreuil, P.

Publikováno v: Europe PubMed Central
Scopus-Elsevier

We recently cloned an additional member of the receptor type tyrosine kinase class III. This new gene, called Flt3 by our group [Rosnet, O., Matteï, M.G., Marchetto, S.Birnbaum, D. (1991). Genomics, 9, 380-385; Rosnet, O., Marchetto, S., deLapeyrier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f81308203723fd45702667c4b6dfcd43
http://europepmc.org/abstract/med/8384358

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.